platinum has been researched along with Cancer, Embryonal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bedard, PL; Chen, EX; Hamilton, RJ; Hansen, AR; Jarvi, K; Lau, S; Lewin, J; Li, X; Malone, ER; Zhang, WJ | 1 |
| Adi, A; Anjary, A; Arghirescu, ST; Boc, AG; Boeriu, AI; Boeriu, E; Borda, A; Feciche, B; Horhat, FG; Horhat, ID; Mot, IC; Negrean, RA; Ravulapalli, M; Sabuni, O | 1 |
| Bleve, S; Casadei, C; Cursano, MC; De Giorgi, U; Gallà, V; Gianni, C; Lolli, C; Martinelli, G; Menna, C; Rosti, G; Schepisi, G | 1 |
| Albany, C; Bokemeyer, C; Brito, M; Cohn-Cedermark, G; Daugaard, G; Gerl, A; Hentrich, M; Necchi, A; Oechsle, K; Oing, C; Seidel, C; Ståhl, O; Taza, F; Tryakin, A | 1 |
| Burger, RA; Cory, L; Giuntoli, RL; Haggerty, AF; Ko, EM; Latif, NA; Morgan, MA; Nasioudis, D | 1 |
| Bakir, MA; Benton, B; Brenton, JD; Broderick, P; Chowdhury, S; Cornish, AJ; de Castro, DG; Dudakia, D; Grist, E; Hiley, C; Holryod, A; Houlston, RS; Huddart, R; Levy, M; Litchfield, K; Loveday, C; Macintyre, G; O'Connor, S; Powles, T; Proszek, PZ; Reid, A; Santo, F; Shipley, J; Swanton, C; Turnbull, C | 1 |
| Kollmannsberger, C; Nappi, L; Nichols, C | 1 |
| Fatima, I; Masood, M; Nisar, H; Sattar, A; Shahid, AB | 1 |
| Müller, AC; Utz, D | 1 |
| Eid, R; Haddad, FG; Kourie, HR; Nemr, E; Semaan, A | 1 |
| Resnick, MJ; Richie, JP | 1 |
| Erk, M; Gamulin, M; Grgić, M; Krasnići, N; Marijić, VF; Pizent, A; Tariba, B; Živković, T | 1 |
| Grüllich, C; Jäger, D; Lasitschka, F; Zschäbitz, S | 1 |
| Bunne, M; Fosså, SD; Gundersen, POM; Osnes, T; Skalleberg, J; Småstuen, MC; Solheim, O | 1 |
| Boos, J; Deuster, D; Dinnesen, AG; Jaehde, U; Krefeld, B; Lanvers-Kaminsky, C; Pieck, AC; Seifert, E; Würthwein, G | 1 |
| Baumgartner, G; Merrin, C; Murphy, GP; Takita, H; Wajsman, Z; Weber, R | 1 |
2 review(s) available for platinum and Cancer, Embryonal
| Article | Year |
|---|---|
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors.
Topics: Cell- and Tissue-Based Therapy; Humans; Immune Checkpoint Inhibitors; Neoplasms, Germ Cell and Embryonal; Platinum; Receptors, Chimeric Antigen | 2023 |
Immunotherapy: last bullet in platinum refractory germ cell testicular cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Drug Resistance, Neoplasm; Humans; Immunotherapy; Neoplasms, Germ Cell and Embryonal; Platinum; Prognosis; Risk Factors; Testicular Neoplasms; Treatment Outcome | 2019 |
14 other study(ies) available for platinum and Cancer, Embryonal
| Article | Year |
|---|---|
Semen and serum platinum levels in cisplatin-treated survivors of germ cell cancer.
Topics: Adult; Cisplatin; Humans; Male; Neoplasms, Germ Cell and Embryonal; Platinum; Semen; Semen Analysis; Survivors; Testicular Neoplasms | 2022 |
Insights on Lipomatosis after Platinum-Based Chemotherapy Use in Pediatric Oncology: A Case Report.
Topics: Child; Cisplatin; Humans; Lipoma; Lipomatosis; Liver Neoplasms; Neoplasms, Germ Cell and Embryonal; Platinum | 2022 |
The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Platinum; Prognosis; Progression-Free Survival; Registries; Survival Rate; Testicular Neoplasms; Young Adult | 2019 |
Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy.
Topics: Adolescent; Adult; Humans; Lymph Node Excision; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Platinum; Young Adult | 2020 |
Genomic landscape of platinum resistant and sensitive testicular cancers.
Topics: DNA Copy Number Variations; Drug Resistance, Neoplasm; Exome Sequencing; Genetic Predisposition to Disease; Genomics; Humans; Male; Mutation; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Platinum; Proto-Oncogene Proteins c-kit; ras Proteins; Signal Transduction; Testicular Neoplasms | 2020 |
Novel treatment options for refractory Germ Cell Tumours: back to the bench!
Topics: Antibodies, Monoclonal, Humanized; Humans; Neoplasms, Germ Cell and Embryonal; Platinum | 2018 |
Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated with Platinum-Based Regimens.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Platinum; Remission Induction; Testicular Neoplasms; Treatment Outcome | 2018 |
[Risk of second malignancies after platinum-based chemotherapy of testicular cancer].
Topics: Cisplatin; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Platinum; Testicular Neoplasms | 2019 |
Re: Risk of Solid Cancer after Treatment of Testicular Germ Cell Cancer in the Platinum Era.
Topics: Humans; Male; Neoplasms, Germ Cell and Embryonal; Platinum; Testicular Neoplasms | 2019 |
Serum metallothionein in patients with testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Agents; Chromatography, Gel; Cisplatin; Humans; Male; Metallothionein; Middle Aged; Neoplasms, Germ Cell and Embryonal; Platinum; Protein Binding; Testicular Neoplasms; Young Adult | 2015 |
Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Cisplatin; Drug Resistance, Neoplasm; Humans; Male; Neoplasms, Germ Cell and Embryonal; Nivolumab; Platinum; Programmed Cell Death 1 Receptor; Testicular Neoplasms | 2016 |
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Audiometry, Pure-Tone; Bleomycin; Case-Control Studies; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Hearing Loss; Humans; Longitudinal Studies; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Platinum; Vinblastine; Young Adult | 2017 |
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Hearing Loss, Sensorineural; Humans; Infant; Infusions, Intravenous; Kidney Diseases; Male; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Osteosarcoma; Platinum; Prospective Studies | 2006 |
Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III).
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Platinum; Testicular Neoplasms; Vinblastine | 1976 |